by Eamon Casey | Feb 12, 2014
Arzezu Sarvestani from massdevice.com wrote an intriguing article on FDA’s Center for Devices and Radiological Health’s (CDRH) outlined priorities for the upcoming 2014 year. One of their main priorities will be in streamlining its clinical trial program with hopes of...
by Eamon Casey | Feb 10, 2014
Alexander Gaffney of raps.org provides a very interesting article on FDA’s move to have a more specialized program to deal with scientific advances and regulatory complexity. Gaffney introduces the article by discussing the cryptic message from FDA saying there was a...
by Eamon Casey | Jan 24, 2014
Richard Knox of NPR introduces to us a fascinating article about the power of the mind in thinking that a pill works when trying to cure an illness. Knox uses two specific illnesses to help show the impact of a placebo in migraines and asthma attacks. With each study...
by Eamon Casey | Jan 24, 2014
Genengnews published an interesting article on the Top 25 mergers and acquisitions (M&A) that occurred in the pharmaceutical world this year. There was a wide variety of purchases ranging in price, technology and geography. What makes this article stand out is the...
by Eamon Casey | Jan 24, 2014
This year’s MAGI Clinical Research Conference will take place May 4-7 in Boston, Massachusetts. Pearl’s Gretchen Bowker will serve on a panel discussing “Regulatory Myths: ‘common’ wisdom about what the rules don’t actually say” during the Regulatory Compliance...
